Molecular Profiling of Advanced Soft-tissue Sarcomas
A phase 3 trial of Nilotinib, Ceritinib, Capmatinib, Lapatinib, Trametinib, Olaparib, Palbociclib and Glasdegib in Sarcomas, run by Institut National de la Santé Et de la Recherche Médicale, France, completed.
Overview
Molecular Profiling of Advanced Soft-tissue Sarcomas is a phase 3 interventional study registered as NCT03784014 by Institut National de la Santé Et de la Recherche Médicale, France, with 603 participants recorded, started 2019-10-19 and reaching its primary completion in 2023-12-01. Interventions recorded: Nilotinib, Ceritinib, Capmatinib, Lapatinib, Trametinib, Trametinib and Dabrafenib, Olaparib and Durvalumab, Palbociclib, Glasdegib, TAS-120, Next Generation sequencing exome. Conditions recorded: Soft Tissue Sarcoma.
Linked to the drug Ceritinib because the registry names it among its interventions and Sarcomas among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialGemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
Shares Glasdegib and the tag pipeline.
- TrialLDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
Shares Ceritinib and the tag pipeline.
- TrialLDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer
Shares Ceritinib and the tag pipeline.
- TrialContinuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
Shares Glasdegib and the tag pipeline.
- TrialA Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer
Shares Lapatinib and the tag pipeline.
- TrialLGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma
Shares Capmatinib and the tag pipeline.
- TrialA Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia
Shares Glasdegib and the tag pipeline.
- TrialA Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
Shares Capmatinib and the tag pipeline.